Han. CD109 is a potential biomarker for malignant tumors. Am J Transl Med [Internet]. 2020 Nov. 12 [cited 2024 May 1];4(3):111-2. Available from: https://ajtm.journals.publicknowledgeproject.org/index.php/ajtm/article/view/589